No 03 2017
Updated: February 3, 2025, 02:36 pm
Published: September 1, 2017
Updated: February 3, 2025, 02:36 pm
Published: September 1, 2017
Top stories
Biotech Business – August 19, 2026
BioArctic and Mesenkia Therapeutics have signed a research collaboration agreement to explore a novel antibody-based approach for glioblastoma, one of the most aggressive and treatment-resistant forms of brain cancer, where effective delivery of large molecules to the brain remains a major challenge.
Collaboration – August 19, 2026
The Lundbeck Foundation has awarded DKK 78 million to a pan-Nordic centre that will focus on research into the glymphatic system.
Collaboration – August 19, 2026
Navinci Diagnostics has initiated a collaboration with BrainZell to explore the use of Navinci’s in situ Proximity Ligation Assay technology in human brain organoid models to support relevant studies of biology and drug response.
In a new job – August 18, 2026
The Board of Directors of BICO Group AB has announced the appointment of Anders Fogelberg, currently Chief Commercial Officer, as President and CEO, effective September 1, 2026.
Related posts
This site uses cookies